Educational Objectives Minimal Residual Disease Flow Cytometry MRD Sensitivity Using Flow Cytometry By Disease State Genetic Methods for MRD Quantification AlleleSpecific Oligonucleotide ASOPCR ID: 337025
Download Presentation The PPT/PDF document "The Role of MRD in Hematologic Malignanc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
The Role of MRD in Hematologic MalignanciesSlide2
Educational ObjectivesSlide3
Minimal Residual DiseaseSlide4
Flow CytometrySlide5
MRD Sensitivity Using Flow CytometryBy Disease StateSlide6
Genetic Methods for MRD QuantificationSlide7
Allele-Specific Oligonucleotide (ASO)-PCRSlide8
MRD Methods – Next Generation SequencingSlide9
MRD Methods – Next Generation SequencingSlide10
ASO-PCR vs NGSSlide11Slide12
Comparison of MRD Assessment ApproachesSlide13
Current Role of MRD Assessment in Clinical CareSlide14
MRD in Acute Lymphoblastic Leukemia
Children’s Oncology Group AALL0232Slide15
COG AALL0232: OutcomesSlide16Slide17Slide18
ALL: Outcomes by Quantitative MRD RangesSlide19
MRD Following HCT in ALLSlide20Slide21
Post Transplant MRD in CLLSlide22Slide23
MRD and Outcomes in MMSlide24
MRD in Non-Hodgkin LymphomaSlide25Slide26Slide27
Summary of MRD in Lymphoid MalignanciesSlide28
Future Perspectives in MRDSlide29
AbbreviationsSlide30
ReferencesSlide31
References (cont)Slide32
References (cont)